Combination Chemotherapy Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or High-Risk Primary Refractory Hodgkin Lymphoma
Clinical trial NCT00574496 · COMPLETED
Trial details
- NCT number
- NCT00574496
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-13
- Primary completion
- 2022-08-02
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.